As of 6 Nov 2026, Kimia Biosciences trades at ₹30.10, 30% below its 52-week high. Debt is 1.96× equity. It is a small-cap company with a market cap of ₹142 Cr, ranked 105th of 154 Drug Manufacturers (Specialty & Generic) companies by market cap; the shares fell 4.7% over the past year.
- ₹31.50
- ₹31.50
- ₹30.10
- ₹30.19
- 71
Health check
- ReturnsBehind
−4.7% over a year, better than 1 of 7 peers.
- Price tagn/a
P/E isn’t reported.
- Growthn/a
Not enough yearly results to measure.
- Profitabilityn/a
Return ratios aren’t reported.
- Balance sheetStretched
Debt 1.96× equity.
- Red flags4 to check
Debt is 1.96× equity.
Small cap
Moves with the market
Key metrics
- Market cap
- ₹142 Cr
- Small cap
- P/E
- n/a
- Industry 28.7
- Price to book
- 6.65
- Peers 4.99
- Dividend yield
- 0.00%
- ROE
- n/a
- Peers 14.7%
- ROCE
- n/a
- Peers 17.9%
- Debt to equity
- 1.96
- Debt ₹35 Cr
- EPS (TTM)
- n/a
- OPM (TTM)
- 6.0%
- Net margin 6.4%
- Sales growth
- −12.1%
- Latest quarter vs a year ago
- Profit growth
- −38.5%
- Latest quarter vs a year ago
- Price to sales
- 1.27
- EV/EBITDA 11.9
Strengths and risks
Risks to check
- Debt is 1.96× equity.
- Quarterly profit down 38.5% on a year ago.
- Quarterly sales down 12.1% on a year ago.
- 30% below its 52-week high.
About Kimia Biosciences
Kimia Biosciences Limited engages in the manufacturing and sale of pharmaceutical products in India and internationally. The company offers active pharmaceutical ingredients (APIs) in various therapeutic categories, including gastrointestinal agent, anti-coagulant, anti-hypertensive, vitamin B1, anti-histamine, anti-convulsant, central stimulant, anti-diabetic, anti-fungal, overactive bladder, anti-inflammatory, prokinetic agent, and hepatoprotective…
- Headquarters
- New Delhi
- Employees
- 205
- Sector
- Healthcare
- ISIN
- INE285U01025
- Website
- kimiabiosciences.com
Price range
- Avg volume (3M)
- 4.1K
- 1-year return
- minus 4.7%
- From 52-week high
- minus 30.5%
Peers · Drug Manufacturers - Specialty & Generic
| Company | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SUNPHARMASun Pharmaceutical Industries | 1,860.00 | plus 1.69% | 4,46,276 | 40.7 | 4.99 | 17.9% | 13.1% | 28.2% | 10.4% | 10.6% | 0.86% | plus 8.2% |
| DIVISLABDivi's Laboratories | 10,320.50 | plus 1.78% | 2,73,977 | 93.6 | 16.35 | 19.0% | 16.2% | 34.9% | 11.0% | 12.1% | 0.29% | plus 49.0% |
| TORNTPHARMTorrent Pharmaceuticals | 4,750.00 | plus 0.85% | 1,80,675 | 80.2 | 9.83 | 9.1% | 15.7% | 33.7% | 13.3% | 20.2% | 0.80% | plus 31.7% |
| LAURUSLABSLaurus Labs | 2,340.00 | minus 0.26% | 1,26,433 | 94.4 | 20.86 | 19.5% | 24.0% | 30.4% | 3.8% | 4.0% | 0.09% | plus 138.6% |
| ZYDUSLIFEZydus Lifesciences | 1,197.90 | plus 0.41% | 1,19,491 | 28.6 | 4.29 | 19.0% | 14.7% | 26.2% | 16.5% | 37.0% | 0.08% | plus 22.8% |
| DRREDDYDr. Reddy's Laboratories | 1,373.00 | plus 0.51% | 1,14,462 | 40.9 | 2.96 | 14.2% | 7.3% | 15.9% | 11.0% | −1.7% | 0.58% | plus 13.8% |
| CIPLACipla | 1,411.00 | plus 0.49% | 1,13,993 | 39.4 | 3.22 | 14.9% | 8.3% | 17.3% | 7.2% | 11.5% | 0.92% | minus 6.6% |
| KIMIABLKimia Biosciences | 30.10 | minus 0.30% | 142 | – | 6.65 | – | – | 6.0% | – | – | 0.00% | minus 4.7% |
| Median of 7 peers | – | 0.51% | 1,26,433 | 40.9 | 4.99 | 17.9% | 14.7% | 28.2% | 11.0% | 11.5% | 0.58% | 22.8% |
Quarterly results
This company doesn’t report these figures in a format we can read yet.
Profit & loss
This company doesn’t report these figures in a format we can read yet.
Forecast
Balance sheet
This company doesn’t report these figures in a format we can read yet.
Cash flow
This company doesn’t report these figures in a format we can read yet.
Shareholding pattern
This company is listed only on BSE, so there’s no NSE category split. See Major shareholders below for the named holders.
Major shareholders
Filings & events
News
No recent news coverage found.